跳至主要内容
临床试验/NL-OMON37066
NL-OMON37066已完成4 期

Systemic antibiotic therapy (amoxicillin plus metronidazole) as an adjunct to initial non-surgical treatment of peri-implantitis; a single blind randomized controlled study - Systemic amoxicillin plus metronidazole in peri-implantitis treatment

niversitair Medisch Centrum Groningen0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) The patient is >= 18 years of age;
  • 2) The patient has at least one endosseous implant in the oral cavity with clinical and radiographical signs of peri-implantitis. Peri-implantitis is defined as a loss of marginal bone >= 2 mm as compared to the shoulder of the implant (the level at which the bone is normally located immediately after implant placement), in combination with bleeding and/or suppuration on probing and a peri-implant probing depth >= 5 mm; ;3) The implants have been in function for at least two years;;4) The patient is capable of understanding and giving informed consent.

排除标准

  • 1) Medical and general contraindications for the surgical procedures;
  • 2) A history of local radiotherapy to the head and neck region;
  • 3) Pregnancy and lactation;
  • 4) Uncontrolled diabetes (HbA1c < 7% or < 53 mmol/mol)
  • 5) Mononucleosis infectiosa
  • 6) Organic neurological disorders
  • 7) Use of antibiotics during the last 3 months;
  • 8) Known allergy to amoxicillin, metronidazole or chlorhexidine;
  • 9) Long-term use of anti-inflammatory drugs;
  • 10) Full edentulism (no remaining teeth, only implants)
  • 11) Incapability of performing basal oral hygiene measures as a result of physical or mental disorders;
  • 12) Implants placed in areas augmented with autogenous bone from the crista iliac region;
  • 13) Implants placed in skin grafted areas;
  • 14) Implants with bone loss exceeding 2/3 of the length of the implant or implants with bone loss beyond the transverse openings in hollow implants;
  • 15) Implant mobility;
  • 16) Implants at which no position can be identified where proper probing measurements can be performed;
  • 17) Previous surgical treatment of the peri-implantitis lesions;
  • 18) Previous non-surgical treatment of the peri-implantitis lesions during the last 6 months (scaling or curretage).

研究者

相似试验